PT Kalbe Farma Tbk (PTKFY) Investment Research Dashboard
About PT Kalbe Farma Tbk (PTKFY) stock analysis
Get live PTKFY stock price $7.70, comprehensive PT Kalbe Farma Tbk stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time PTKFY stock data and investment insights.
Loading chart data...
PT Kalbe Farma Tbk (PTKFY) Overview
PT Kalbe Farma Tbk (PTKFY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, PTKFY trades at $7.70 with a market capitalization of 8.72M . Over the past 52 weeks, PTKFY has traded between $7.63 and $18.59 , with the current price positioned at approximately 1% of this range . The stock curren...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 8.72M
- Current price: $7.70
- 52-week range: $7.63 - $18.59
- P/E ratio: 9.79
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescr...
Company Information
- CEO
- Bernadette Ruth Setiady
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 12835
Contact Information
- Website
- https://www.kalbe.co.id
- Address
- Gedung KALBE
- Country
- ID
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.8)
✓ Lower volatility stock (Beta: -0.04) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for PT Kalbe Farma Tbk shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for PT Kalbe Farma Tbk
- ⚠Investors should consider how PT Kalbe Farma Tbk fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
8.72M
P/E Ratio (TTM)
9.79
Beta
-0.04
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PTKFY with peer companies:
- Price
- $0.10-12.22% (1D)
- Market cap
- 2.74M
- Price
- $0.05+0.00% (1D)
- Market cap
- 3.83M
- Price
- $0.03-4.95% (1D)
- Market cap
- 7.79M
- Price
- $0.80+0.00% (1D)
- Market cap
- 46.84M
- Price
- $0.85+2.41% (1D)
- Market cap
- 10.88M
- Price
- $1.21-8.33% (1D)
- Market cap
- 1.06M
- Price
- $0.02+0.00% (1D)
- Market cap
- 3.38M
- Price
- $0.00+0.00% (1D)
- Market cap
- 110.27K
- Price
- $0.32+5.27% (1D)
- Market cap
- 26.01M
- Price
- $0.04-11.29% (1D)
- Market cap
- 11.46M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.